Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
anti-BCMA CAR-T cells / Hrain Biotech
NCT05594797: Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM	Recruiting	2	100	RoW	Human BCMA Targeted T Cells Injection, BCMA CAR-T	Hrain Biotechnology Co., Ltd., Shanghai Changzheng Hospital, First Affiliated Hospital of Wenzhou Medical University	Multiple Myeloma	07/25	07/27
NCT03943472: BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma	Recruiting	1	10	RoW	Anti-BCMA CAR-T cells, Fludarabine, Cyclophosphamide, Immune inhibitors	Hrain Biotechnology Co., Ltd., Shanghai Changzheng Hospital	Multiple Myeloma	11/21	05/22
NCT05302648: To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM	Active, not recruiting	1	18	RoW	Human Derived anti-BCMA CAR-T Injection, BCMA CAR-T	Hrain Biotechnology Co., Ltd., Shanghai Changzheng Hospital	Multiple Myeloma	12/24	12/25